Results 91 to 100 of about 37,127 (212)
BMC Infectious Diseases, 2019 Background Multidrug-resistant tuberculosis (MDR-TB) requires lengthy use of second-line drugs, burdened by many side effects. Hepatitis C virus (HCV) chronic infection increases risk of drug-induced liver injury (DILI) in these patients.
Maria Musso +9 more
doaj +1 more source
A real‐world experience with 6 months of antitubercular therapy in abdominal tuberculosis
JGH Open, 2019 Abdominal tuberculosis is an important form of extrapulmonary tuberculosis. Evidence from clinical trials suggests that 6 months of antitubercular therapy (ATT) is sufficient for abdominal tuberculosis.
H. Mandavdhare +3 more
semanticscholar +1 more source
Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
Yahya Almodallal +4 more
wiley +1 more source
Studies on new substituted pyridazinones: synthesis and biological evaluation
Brazilian Journal of Pharmaceutical Sciences, 2018 We report herein the synthesis and pharmacological evaluation of a new series of 6-aryl-2-(imidazol-1-yl/1,2,4-triazol-1-yl)-2-methyl-4,5-dihydro-(2H)-pyridazin-3-one (3a-j) as potential anticonvulsant and antitubercular agents.
Mohammad Asif +3 more
doaj +1 more source
Antitubercular Triazines: Optimization and Intrabacterial Metabolism [PDF]
, 2019 Xin Wang +25 more
openalex +1 more source
Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
Case Reports in Gastroenterology, 2011 Pseudomembranous colitis (PMC) may develop with long-term antibiotic administration, but is rarely reported to be caused by antitubercular agents. We present a case of PMC that occurred 120 days after starting rifampicin.
Jeong Moon Choi +4 more
doaj +1 more source
Chemical Physics ImpactThe objective of this study was to develop and verify a QSAR model for predicting the antitubercular effects of trisubstituted benzimidazole derivatives. For this study, 50 compounds with antitubercular activity targeting FtsZ protein were retrieved from
Anguraj Moulishankar, T. Sundarrajan
doaj +1 more source
Design of potent fluoro-substituted chalcones as antimicrobial agents
Journal of Enzyme Inhibition and Medicinal Chemistry, 2017 Owing to ever-increasing bacterial and fungal drug resistance, we attempted to develop novel antitubercular and antimicrobial agents. For this purpose, we developed some new fluorine-substituted chalcone analogs (3, 4, 9–15, and 20–23) using a structure ...
Serdar Burmaoglu +8 more
doaj +1 more source
Crystal engineering of pharmaceutical solids involving antitubercular drugs [PDF]
, 2007 Victor Kravtsov
openalex +1 more source